Skip to main content
Log in

CASE REPORT: Troglitazone-Induced Fulminant Hepatic Failure

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994

    Google Scholar 

  2. Schwartz S, Raskin P, Fonseca V, Graveline JF: Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. N Engl J Med 338:861-866, 1998

    Google Scholar 

  3. Watkins PB, Whitcomb RW: Hepatic dysfunction associated with troglitazone. N Engl J Med 338:916-917, 1998 (letter)

    Google Scholar 

  4. Gitlin N, Julie NL, Spurr CL, Lim KN, Juarbe HM: Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Ann Intern Med 129:36-38, 1998

    Google Scholar 

  5. Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, Brunt EM: Troglitazone-induced hepatic failure leading to liver transplantation. Ann Intern Med 129:38-41, 1998

    Google Scholar 

  6. Shibuya A, Watanabe M, Fujita Y, Saigenji K, Kuwao S, Takahashi H, Takeuchi H: An autopsy case of troglitazoneinduced fulminant hepatitis. Diabetes Care 21:2140-2143, 1998

    Google Scholar 

  7. Vella A, de Groen PC, Dinneen SF: Fatal hepatotoxicity associated with troglitazone. Ann Intern Med 129:1080, 1998 (letter)

    Google Scholar 

  8. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998

    Google Scholar 

  9. Farrell GC: Liver disease caused by drugs, anesthetics, and toxins. In Gastrointestinal Disease. M Feldman, BF Scharschmidt, MH Sleisenger (eds). Philadelphia, WB Saunders, 1998, pp 1221-1252

    Google Scholar 

  10. Bass NM, Ockner RK: Drug-induced liver disease. In Hepatology. D Zakim, TD Boyer (eds). Philadelphia, WB Saunders, 1996, pp 962-1017

    Google Scholar 

  11. Parke-Davis: Prescribing information for Rezulin. Parke-Davis, Morris Plains, New Jersey, July 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, E.J., Davern, T.J., Shakil, A.O. et al. CASE REPORT: Troglitazone-Induced Fulminant Hepatic Failure. Dig Dis Sci 45, 549–553 (2000). https://doi.org/10.1023/A:1005405526283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005405526283

Navigation